Cihan Papan

clinical microbiologist / ped / ID specialist / interested in diagnostics, antimicrobial stewardship, AI & med. education
Professor at HHU Düsseldorf

[Cihan Papan @CihanPapan]

#IDTwitter
How often are antimicrobials given in pediatric hematology/oncology, and how often is it appropriate?
We conducted a multi-center point-prevalence study (PPS) in 🇩🇪 and 🇦🇹
What’s more, we checked EACH prescription for appropriateness  
Here is what we found —>
1/11

[Cihan Papan @CihanPapan]

We are hiring / wir stellen ein:
Fachärzt*in / Assistenz*ärztin / Clinician Scientist
https://t.co/hjtSERP0Ak

[Cihan Papan @CihanPapan]

I have started my Professorship for Molecular Medical Microbiology and Infection Immunology at the Heinrich Heine University Düsseldorf @UniklinikDUS as of 1st May 🎉 🍾
Looking forward to continuing established and starting new collaborations with interested folks!

[Cihan Papan @CihanPapan]

#ESPID2025 #IDtwitter
@ESPIDsociety
New Vaccines in Town:
Paratyphoid vaccine could become the first to be licensed on basis of controlled human infection model (CHIM)
@AndrewPollard

[WikiGuidelines @Wiki_Guidelines]

We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to @zacroBID and @amenalor for leading the effort.

https://t.co/XC2MgtjTdb

[Cihan Papan @CihanPapan]

A heartfelt thank you to the @PaulEhrlichGes for honouring our work with the Wolfgang Stille Award 🙏
here is the link to the paper:
https://t.co/eAkz7nD7Xb
@LancetRH_Europe

[guido werner @guwe33]

Wolfgang Stille award of the @PaulEhrlichGes this year goes to 2 winners: congrats to the working group of @CihanPapan and Dr Tan for two excellent studies published in 2023/2024
https://t.co/WPTysVqMNO

[The Lancet Digital Health @LancetDigitalH]

New Comment from Yael Lohse and colleagues: Migration background, skin colour, gender, and infectious disease presentation in clinical vignettes.

Read it here: https://t.co/UbfPkEABpg

[Cihan Papan @CihanPapan]

#ESCMIDGlobal2024
David Resnik on why #AI #LLM such as ChatGPT do not qualify as authors of a publications
—> lack of accountability
—> lack of moral responsibility
Among other arguments
@ESCMID

[Cihan Papan @CihanPapan]

#ESCMIDGlobal2024
Highly engaging talk and discussion on the potentials and perils of large language models #LLM in medicine @GermHunterMD
Hall B
@ESCMID #AI

[Cihan Papan @CihanPapan]

Observed even a
Decreased infection rate

Intriguing findings given the not-so-bad baseline compliance rates already

#ESCMIDGlobal2024

[Cihan Papan @CihanPapan]

Tobias Kramer from @ChariteBerlin reporting findings of their cluster-randomized trial on hand hygiene intervention in outpatient hemodialysis centers
#ESCMIDGlobal2024 @ESCMID

[Cihan Papan @CihanPapan]

Multimodal intervention led to increased compliance in almost all hand hygiene moments

[Cihan Papan @CihanPapan]

#ESCMIDGlobal2024
Nicholas Grassly on the potential of wastewater surveillance for other pandemic-risk viruses, e.g. #Zika #Lassa

Hall I

[Cihan Papan @CihanPapan]

#ESCMIDGlobal2024
ESCMID Study Group for Antimicrobial Stewardship

Business Meeting — the room is packed

[Cihan Papan @CihanPapan]

tl;dr:
- Although BV score differentiates well between bacterial and viral RTI —> use with caution in “atypical” pathogens like Mp
- Although imperfect in Mp —> microbiological testing remains important
- These findings come in time as Mp resurges —> https://t.co/ErOIRJL8t6

[Cihan Papan @CihanPapan]

#IDTwitter
📢Just published🔥
The BV score (TRAIL + IP10 + CRP) discriminates quite well between bacterial and viral respiratory tract infections (RTI).
But how does it perform in #pneumonia caused by Mycoplasma pneumoniae (Mp)?
https://t.co/855FfcMnZm
1/n

[Cihan Papan @CihanPapan]

Finding #2:
Combining clinical features (age, duration of fever, duration of resp. symptoms) with BV performed as well as combining them with PCT (AUC 0.86 vs. 0.87) in terms of discriminatory accuracy

6/n